Introduction Despite recent advances in treatment, lung cancer remains the leading cause of cancer-related death, morbidity and burden of disease in Australia.1 To achieve the best possible outcomes, patients must receive optimal evidence-based care, which includes timely and equitable access to diagnostic testing and appropriate treatment modalities. In March 2020, the World Health Organization (WHO) declared the coronavirus disease 2019 (COVID-19) a global pandemic.